Xpeng (XPEV) has had the highest return since November 10, 2025 by a large-cap US stock, returning 18.3%.
| ASSET | % RETURN |
|---|---|
Xpeng (XPEV) | 18.34% |
Rivian Automotive (RIVN) | 15.96% |
Tower Semiconductor (TSEM) | 14.69% |
Viatris (VTRS) | 10.36% |
QXO (QXO) | 10.26% |
Coca-Cola Consolidated (COKE) | 10.12% |
Vodafone Group PLC ADR (VOD) | 9.51% |
Rocket Companies (RKT) | 9.24% |
AngloGold Ashanti (AU) | 8.82% |
Madrigal Pharmaceuticals (MDGL) | 8.73% |
Akamai Technologies (AKAM) | 8.11% |
BridgeBio Pharma (BBIO) | 7.16% |
Becton Dickinson and (BDX) | 6.9% |
Moderna (MRNA) | 6.71% |
Laboratory Corporation of America (LH) | 6.61% |
SoFi Technologies (SOFI) | 6.5% |
Huazhu (HTHT) | 6.45% |
Novo Nordisk A-S (NVO) | 6.34% |
Carvana (CVNA) | 6.32% |
Quest Diagnostics (DGX) | 5.98% |
Align Technology (ALGN) | 5.88% |
Biomarin Pharmaceutical (BMRN) | 5.75% |
Amgen (AMGN) | 5.57% |
DexCom (DXCM) | 5.38% |
Snap (SNAP) | 5.29% |
Large-cap stocks are treated as having a market cap of $10B+.
